Recruiting

Using CircuLating Tumor DNA to Risk Adapt Post-Operative Therapy for HPV-associated Oropharyngeal Cancer

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(4 sites)

United States

Cedars-Sinai Cancer at Beverly Hills (THO), Beverly Hills, California

Cedars Sinai Medical Center, Los Angeles, California

CS Cancer at Valley Oncology Medical Group, Tarzana, California

CS Cancer at the Hunt Cancer Center, Torrance, California